• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21721 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     NIHR Health Technology Assessment programme Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS)
2008     NIHR Health Technology Assessment programme Randomised trial of fluoxetine and cognitive-behavioral therapy versus fluoxetine alone in adolescents with persistent major depression - primary research
2005     Agency for Healthcare Research and Quality (AHRQ) Randomized trials of secondary prevention programs in coronary artery disease: a systematic review
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for choroidal neovascularisation and macular oedema
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for diabetic macular oedema
2009     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for macular oedema secondary to central or branch retinal vein occlusion
2008     HAYES, Inc. Ranibizumab (Lucentis) for neovascular age-related macular degeneration
2011     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for visual impairment due to choroidal neovascularisation (CNV) secondary to pathological myopia - first line
2008     NIHR Health Technology Assessment programme Ranibizumab and pegaptanib for the treatment of age-related macular degeneration - technology assessment report for NICE, ref 04/24/01
2008     NIHR Health Technology Assessment programme Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation
2005     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab for age-related macular degeneration - horizon scanning review
2013     NIHR Health Technology Assessment programme Ranibizumab for the treatment of choroidal neovascularisation associated with pathological myopia
2011     NIHR Health Technology Assessment programme Ranibizumab for the treatment of diabetic macular oedema
2011     NIHR Health Technology Assessment programme Ranibizumab for the treatment of macular oedema caused by retinal vein occlusion (RVO): a single technology appraisal
2015     Medical Services Advisory Committee (MSAC) Ranibizumab for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO)
2022     Agency for Care Effectiveness (ACE) Ranibizumab for treating age-related macular degeneration, diabetic macular oedema and retinal vein occlusion
2008     The Swedish Council on Health Technology Assessment (SBU) Ranibizumab in treating age-related macular degeneration
2014     Andalusian Health Technology Assessment Area (AETSA) Ranizumab and bevacizumab for the treatment of diabetic macular oedema.
2003     University HealthSystem Consortium (UHC) Ranolazine
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Ranolazine (Ranexa (TM)) for chronic stable angina
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ranolazine (Ranexa®)
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ranolazine (Ranexa®) as add-on therapy for symptomatic treatment of stable angina pectoris
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ranolazine for the treatment of stable angina
2002     NIHR Horizon Scanning Centre (NIHR HSC) Ranpirnase for mesothelioma - horizon scanning review
2008     Agenzia nazionale per i servizi sanitari regionali (Agenas) Rapid (bed-side) tests for influenza
2007     HAYES, Inc. Rapid antibody testing for HIV
2011     HAYES, Inc. Rapid antibody tests for HIV screening
2020     Health Technology Wales (HTW) Rapid antigen detecting tests for diagnosing group A streptococcal infections in the community pharmacy setting
2020     NIHR Health Technology Assessment programme Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation
2021     Health Information and Quality Authority (HIQA) Rapid antigen testing for screening or surveillance of asymptomatic individuals to limit transmission of SARS-CoV-2
2008     Belgian Health Care Knowledge Centre (KCE) Rapid assessment of a selection of new treatments for prostate cancer and benign prostate hypertrophy
2006     Belgian Health Care Knowledge Centre (KCE) Rapid assessment of emerging spine technologies: intervertebral disc replacement and vertebro/balloon kyphoplasty
2014     Malaysian Health Technology Assessment (MaHTAS) Rapid blood test device for HIV, HBV, HCV, & syphillis
2008     Adelaide Health Technology Assessment (AHTA) Rapid breath test for assessing total body water in chronic kidney disease patients
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Rapid cholesterol test
2020     European Network for Health Technology Assessment (EUnetHTA) Rapid collaborative review on the current role of antibody tests for novel coronavirus SARS-COV-2 in the management of the pandemic
2020     European Network for Health Technology Assessment (EUnetHTA) Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of SARS-COV-2 virus in people with suspected COVID-19
2020     Health Technology Wales (HTW) Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of the SARS-COV-2 virus in people with suspected COVID-19
2015     NIHR Health Technology Assessment programme Rapid detection of health-care-associated bloodstream infection in critical care using multipathogen real-time polymerase chain reaction technology: a diagnostic accuracy study and systematic review
2023     NIHR Health and Social Care Delivery Program Rapid evaluation of service innovations in health and social care: key considerations
2023     NIHR Health Services and Delivery Research programme Rapid evaluation of the Special Measures for Quality and challenged provider regimes: a mixed-methods study
2013     NIHR Health Technology Assessment programme Rapid fetal fibronectin (fFN) testing to predict pre-term birth in women with symptoms of premature labour: A systematic review and cost-effectiveness analysis
2020     Health Information and Quality Authority (HIQA) Rapid health technology assessment of alternative diagnostic testing approaches for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2023     Health Information and Quality Authority (HIQA) Rapid health technology assessment of continuous glucose monitoring in adults with type 1 diabetes mellitus
2023     Health Information and Quality Authority (HIQA) Rapid health technology assessment of the extension of the seasonal influenza vaccination programme to include those aged 50 to 64 years (general population)
2010     Adelaide Health Technology Assessment (AHTA) Rapid molecular assays for the diagnosis of sepsis and identification of sepsis causing pathogens
2006     Adelaide Health Technology Assessment (AHTA) Rapid point-of-care for the detection of Chlamydia in individuals at risk of trachoma
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Rapid response testing for the detection of clostridium difficile: a review of the diagnostic accuracy
2008     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid Review - Clinical treatments for wrist ganglia. Report No. 63.
2008     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid Review - Diagnostic arthroscopy for conditions of the knee. Report No. 64.
2008     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid Review - Non-therapeutic male circumcision. Report No. 65.
2008     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid Review - Treatments for varicose veins. Report No. 66.
2008     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid Review - Upper airway surgery for the treatment of adult obstructive sleep apnoea. Report No. 67.
2021     Health Information and Quality Authority (HIQA) Rapid review of public health guidance for residential care facilities in the context of COVID-19
2021     Health Information and Quality Authority (HIQA) Rapid review of public health guidance on protective measures for vulnerable groups in the context of COVID-19
2008     Quality Improvement Scotland (NHS QIS ) Rapid review of the front-loaded model (FLM) and proposed application within the Scottish Ambulance Service (SAS)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rapid Rhythm ECG for atrial fibrillation
2016     Adelaide Health Technology Assessment (AHTA) Rapid sepsis detection
2008     NIHR Health Technology Assessment programme Rapid systematic review of the impact of participation in research
2008     Adelaide Health Technology Assessment (AHTA) Rapid test for Helicobacter pylori diagnosis of patients presenting with symptoms of dyspepsia
2009     Adelaide Health Technology Assessment (AHTA) Rapid testing and targeted population screening for Helicobacter pylori
2009     NIHR Health Technology Assessment programme Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness
2023     Agency for Care Effectiveness (ACE) Rapid to aid the diagnosis of patients suspected of stroke
2007     Adelaide Health Technology Assessment (AHTA) Rapid transcranial magnetic stimulation for stroke rehabilitation
2009     Adelaide Health Technology Assessment (AHTA) Rapid urine test for Chlamydia trachomatis
2007     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid versus full systematic reviews: an inventory of current methods and practice in Health Technology Assessment. Report no 60
2014     NIHR Horizon Scanning Centre (NIHR HSC) RAPIDEC® CARBA NP test for confirmation or detection of Carbapenemase producing bacteria
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rarunavir/cobicistat (Rezolsta®)
2014     Medical Services Advisory Committee (MSAC) RAS (Kirsten RAS and Neuroblastoma RAS) mutation testing for eligibility for panitumumab treatment in previously untreated metastatic colorectal cancer patients.
2004     University HealthSystem Consortium (UHC) Rasagiline
2006     HAYES, Inc. Rasagiline for treatment of Parkinson's disease
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Rasburicase and hyperuricemia in cancer patients
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Rasburicase for adults with acute tumor lysis syndrome: a review of clinical and cost effectiveness and safety
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Rate control versus serial electric cardioversion forchronic atrial fibrillation - primary research
2023     NIHR Health Technology Assessment programme Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study
2003     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Rational antibiotic utilisation in selected paediatric conditions
2003     Malaysian Health Technology Assessment Unit (MHTAU) Rational antibiotic utilisation in selected paediatric conditions
2005     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Rational use of analgesics in paediatrics
2006     Malaysian Health Technology Assessment Unit (MHTAU) Rational use of analgesics in paediatrics
1999     Unidad De Tecnologias De Salud (ETESA) Rational use of colloid solutions. Part I
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rational vaccination policies - decision support. Review of international literature for "rational" vaccination policies
2021     Scottish Medicines Consortium (SMC) Ravulizumab for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH): in patients with haemolysis with clinical symptom(s) indicative of high disease activity; in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months
2022     NIHR Health Technology Assessment programme RCT of clinical and cost-effectiveness of drug coated balloons, drug eluting stents and balloon angioplasty with bail-out bare metal stent revascularisation strategies for severe limb ischaemia due to femoro-popliteal disease: BASIL-3 (Balloon vs Stenting in Severe Ischaemia of the Leg)
2008     University of York RCTs for policy interventions? A review of reviews and meta-regression - systematic review
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme: from assessment to expert appraisal
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme. Part XI: Further development of the mother-child-pass: Screening recommendations of the expert working group for pregnancy, puerperium and early childhood (0-6 years)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
1996     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Re-use of medical devices
2017     NIHR Health Services and Delivery Research programme REACH: a mixed-methods study to investigate the measurement, prediction and improvement of retention and engagement in outpatient HIV care
2016     NIHR Horizon Scanning Centre (NIHR HSC) ReActiv8® implantable device for treating chronic low back pain
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Real-time (synchronous) telehealth in primary care: systematic review of systematic reviews
2014     Andalusian Health Technology Assessment Area (AETSA) Real-time 3D Transesophageal Echocardiography (RT-3D-TEE) versus 2D.
2009     Medical Services Advisory Committee (MSAC) Real-time measurement of cardiac output and other cardiac flow parameters (without concurrent cardiac imaging) using continuous wave Doppler techniques
2017     NIHR Health Technology Assessment programme Real-time modelling of a pandemic influenza outbreak
2021     Center for Drug Evaluation (CDE) Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System
2011     NIHR Horizon Scanning Centre (NIHR HSC) RealTime mS9 Colorectal Cancer (CRC) assay for the early detection of colorectal cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Reassessment of health technologies: obsolescence and waste
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Rebetron - hepatitis C
1994     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Receptor-imaging somatotropine inhibitor factor analogue in endocrine oncology - primary research